NovaBridge Biosciences Capital Reinvestment Ratio
NovaBridge Biosciences capital reinvestment ratio. NovaBridge Biosciences (NBP) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($13.15 Million) in capital expenditures ($41.00). Check NBP capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NovaBridge Biosciences (2020–2020)
Capital reinvestment ratio of NovaBridge Biosciences from 2020 to 2020. This chart tracks NovaBridge Biosciences's Capital Reinvestment Ratio across 1 annual periods. Also explore NBP shareholders equity momentum to track the company's year-over-year net asset growth rate.
NovaBridge Biosciences Capital Reinvestment Ratio by Year (2020–2020)
NovaBridge Biosciences capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see NBP cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | $433.56 Million | $8.01 Million | — |